Jonathan remembers the first time he saw blood in his urine. It was his and Mandy’s anniversary. We are honoured to work with Jonathan and his wife, Mandy, to share the story of his bladder cancer diagnosis. Through months of cystectomies, surgeries and finally, BCG treatments, Jonathan thought to capture the ups and downs ofRead more
Blog
Critical Bladder Cancer Drug Now Fully Available After Years of Shortages Health Canada releases VERITY-BCG™ bladder cancer treatment for distribution From Verity Pharmaceuticals: TORONTO, Sept. 9, 2021 /CNW/ – Verity Pharmaceuticals Inc. is pleased to announce that it has received approval to begin distributing VERITY-BCG™ (Bacillus Calmette-Guérin [BCG]: Strain Russian BCG-I). This approval means that hospitals and clinics across Canada will no longerRead more
By: Tawny Barratt Read time: 16 minutes Thanks so much for joining us during Bladder Cancer Awareness month! There are currently 80,000 Canadians currently living with a bladder cancer diagnosis and 12,000 more will be diagnosed this year. At Bladder Cancer Canada, we are doing everything we can to increase awareness of this devastating diseaseRead more
DATE: MAY 17, 2021 TORONTO – On behalf of the Board of Directors of Bladder Cancer Canada, Survivor and Volunteer Board Chair Ferg Devins is delighted to announce the appointment of Michelle Colero to the position of Executive Director for the national organization. “Michelle brings incredible strengths to the Bladder Cancer Canada team,” remarked survivor andRead more
As seen in www.healthinsights.ca. There are 80,000 Canadians living with bladder cancer, and many of them are younger than you’d think. Here’s one family’s story about why awareness and early detection are critical in saving lives. “On Nov. 27th, 2020, I lost my husband and father to our three-year-old daughter to metastatic bladder cancer. JohnRead more
Our latest newsletter includes Michelle, our Executive Director, Shirley, our volunteer Communications Assistant and Jonathan, a bladder cancer patient! Subscribe today! Michelle Colero is Bladder Cancer Canada’s new Executive Director and has been with us since May this year, when she hit the ground running in her leadership efforts to guide the organization in ourRead more
By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back about five years ago when the Kingston resident was diagnosed with both bladder and prostate cancer. As he was undergoing treatment,Read more
Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way about how the this virus might affect their health and treatments. We will be answering many of these questions after consulting with theRead more
(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues to spread globally, many people have become concerned about contracting this disease. For cancer patients and survivors that have a compromisedRead more
In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patients with locally advanced or metastatic urothelial carcinoma with certain FGFR genetic alterations. Health Canada has approved the therapy on the conditionRead more
